Open-architecture interference screw

Information

  • Patent Grant
  • 9808298
  • Patent Number
    9,808,298
  • Date Filed
    Wednesday, April 9, 2014
    10 years ago
  • Date Issued
    Tuesday, November 7, 2017
    6 years ago
Abstract
The present disclosure relates to an interference screw for creating an interference fit between a bone tunnel and tissue. The screw includes a threaded body having a proximal end, distal end, and thread extending around the threaded body between the proximal and distal ends. A supporting spline extends along a cannulation through the threaded body. The supporting spline is engagable with a delivery device. The screw further includes at least one opening defined by a surface between threads of the threaded body. A ratio of open surface area to closed surface area defines the opening and is selected such that, when torsionally loaded, the screw does not exhibit plastic deformation when inserted into an undersized bone tunnel. The screw further includes a tapered tip extending from the distal end of the threaded body. The tapered tip has a thread extending at least partway around the tapered tip.
Description
BACKGROUND

Interference screws have proven to be an effective means for securing tissue in a bone tunnel. However, the interference screw itself generally takes up a substantial amount of space within the bone tunnel, which can limit the surface area contact established between the tissue and the side wall of the bone tunnel. This in turn limits the region of bone-to-tissue in-growth, and hence can affect the strength of the repair. By way of example but not limitation, it has been estimated that the typical interference screw obstructs about 50% of the potential bone-to-tissue integration region.


SUMMARY

In one aspect, the present disclosure relates to an open-architecture interference screw for creating an interference fit between a bone tunnel and tissue. The interference screw includes a threaded body having a proximal end and a distal end, and a thread extending around the threaded body between the proximal end and distal end. The interference screw further includes a supporting spline extending along a cannulation through the threaded body between the proximal end and distal end. The supporting spline is engagable with a delivery device. The interference screw further includes at least one opening defined by an outer surface between the thread. The at least one opening is further defined by a ratio of open surface area to closed surface area. The ratio is selected such that, when torsionally loaded, the screw does not exhibit plastic deformation when inserted into an undersized bone tunnel. The interference screw further includes a tapered tip extending from the distal end of the threaded body. The tapered tip has a thread extending at least partway around the tapered tip.


In yet another aspect, the present disclosure relates to a delivery device and interference screw combination for creating an interference fit between a bone tunnel and tissue. The delivery device of the combination includes a handle and a shaft connected to the handle. The shaft includes a distal portion having a driving member. The interference screw includes a threaded body having a proximal end and a distal end, and a thread extending around the threaded body between the proximal end and distal end. The interference screw further includes a supporting spline extending along a cannulation through the threaded body between the proximal end and distal end. The supporting spline is engagable with a delivery device. The interference screw further includes at least one opening defined by an outer surface between the thread. The at least one opening is further defined by a ratio of open surface area to closed surface area. The ratio is selected such that, when torsionally loaded, the screw does not exhibit plastic deformation when inserted into an undersized bone tunnel. The interference screw further includes a tapered tip extending from the distal end of the threaded body. The tapered tip has a thread extending at least partway around the tapered tip. The interference screw is located on the distal portion of the delivery device such that the driving member engages the supporting spline of the interference screw.


In some examples, the interference screw may further include one or more of the following, alone or in any combination. The thread of the tapered tip may extend at least one full turn around the tapered tip. The thread of the tapered tip may also be a continuation of the thread of the threaded body. In other examples, the thread of the tapered tip is a partial thread extending less than one full turn around the tapered tip. Some of these examples include a first partial thread and a second partial thread, each extending a half turn around the tapered tip.


In some examples, the threaded body and tapered tip each have a different thread pitch. The thread pitch of the tapered tip may be between 1.5 and 3 times greater than the thread pitch of the threaded body.


In other examples, the threaded body has a constant diameter. The threaded body may have a wall thickness of 0.5-3.25 mm or a wall thickness that is a function of the diameter and length of the screw. The supporting spline may have a width of 1-2.5 mm. The thread of the threaded body may have a base width of 0.76-2.54 mm.


In some examples, the ratio of open surface area to closed surface area is a function of the diameter and length of the screw. In one example, in which the screw has a diameter of 11-12 mm and a length of 30-35 mm, the ratio is about one unit of open surface area to about three units of closed surface. In another example, in which the screw has a diameter of 7-10 mm and a length of 20-35 mm, the ratio is about one unit of open surface area to about four units of closed surface area. In yet another example, in which the screw has a diameter of 5-6 mm and a length of 20-25 mm, the ratio is about one unit of open surface area to about five units of closed surface area.


The at least one opening may be defined by a surface between adjacent proximal threads. Alternatively, the at least one opening may include at least one continuous opening between adjacent proximal threads and at least one discontinuous opening between adjacent distal threads. In this example, the at least one discontinuous opening has alternating segments of open surface area and closed surface area. In yet another example, the at least one opening is defined by a surface between alternating pairs of adjacent threads.


Other examples of the interface screw include a screw head comprising a surface extending from the threaded body into a hemispherical-like end portion.


Some examples of the interface screw are made from made from a combination of poly(lactic-co-glycolic) acid, β-Tricalcium phosphate, and calcium sulfate.


Further areas of applicability of the present disclosure will become apparent from the detailed description provided hereinafter. It should be understood that the detailed description and specific examples, while indicating the convenient example of the disclosure, are intended for purposes of illustration only and are not intended to limit the scope of the disclosure.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and form a part of the specification, illustrate examples of the present disclosure and together with the written description serve to explain the principles, characteristics, and features of the disclosure. In the drawings:



FIGS. 1A-B are views of an example of an open-architecture interference screw.



FIGS. 2A-B are views of another example of the open-architecture interference screw.



FIGS. 3A-C are views of an example combination of driver and open-architecture interference screw.



FIGS. 4A-C are views of an example of another open-architecture interference screw.



FIGS. 5A-D are views of another example of the open-architecture interference screw.



FIGS. 6A-C are views of another example of the open-architecture interference screw.



FIGS. 7A-C are views of another example of the open-architecture interference screw.



FIGS. 8A-C are views of another example of the open-architecture interference screw.



FIGS. 9A-B are views of an example combination of driver and open-architecture interference screw.



FIGS. 10A-B are side views of an example open-architecture interference screw having a tapered tip with two partial threads.



FIG. 10C-D are views of the tapered tip of FIGS. 10A-B with the body of the screw removed for clarity.



FIG. 11 is a view of an example tapered tip with one partial thread.





DETAILED DESCRIPTION OF THE EMBODIMENTS

The following description of the example is in no way intended to limit the disclosure, its application, or uses.



FIGS. 1A and 1B show an example of an interference screw 100. The interference screw 100 includes a threaded body 105 having a proximal end 106 and a distal end 107. A majority of the threaded body 105 includes screw threads 110 in the form of a helical coil, i.e. a connected series of continuous regularly spaced turns extending in a helical or spiral form substantially from the proximal end 106 to the distal end 107. The interference screw 100 further includes at least one opening 115 being defined by a surface between threads 110 of the threaded body 105. The opening 115 is further defined by a ratio of open surface area to closed surface area. It may convenient to refer to the ratio as a measure of degree of openness of an open architecture interference screw.


Having a ratio of open surface area to closed surface area is particularly advantageous, inasmuch as the ratio provides the structural strength (e.g., torsional, flexural, and/or compressive strengths) needed to set the interference screw 100 into position, and hold the tissue in position while bone-to-tissue in-growth occurs, while still providing extraordinary access through the threaded body 105 of the interference screw 100. Thus, cell and nutrient-bearing fluids can move substantially unimpeded through the threaded body 105 of interference screw 100, and tissue in-growth can occur across the threaded body 105 of interference screw 100.


A convenient example of the interference screw 100 has a ratio of open surface area to closed surface area that is a function of the diameter and length of the interference screw 100. For example, the ratio of open surface area to closed surface area increases as the length and/or diameter of the interference screw 100 increases. Described below in greater detail, a large-sized example of the interference screw 100, having a diameter of 11 mm-12 mm and a length of 30 mm-35 mm, has a ratio of about one unit of open surface area to about three units of closed surface area. A medium-sized example of the interference screw 100, having a diameter of 7 mm-10 mm and length of 20-35 mm, has a ratio of about one unit of open surface area to about four units of closed surface area. A small-sized example of the interference screw 100, having a diameter of 5-6 mm and a length of 20 mm-25 mm, has a ratio of about one unit of open surface area to about five units of closed surface area.


As best seen in FIG. 1A, there are openings 115 between adjacent proximal threads 120a,b of the interference screw 100. The interference screw 100 also includes closed surfaces 125 between adjacent distal threads 130a,b. As shown, the interference screw 100 is arranged with an open proximal portion and closed distal portion. This arrangement is advantageous because the closed surface 125 enhances the torsional strength, compressive strength and/or fexural strength (bend strength) of the distal portion of the interference screw 100. Increased structural strength is desirable at the distal end 107 of the interference screw 100 because it is prone to breaking as the interference screw 100 is inserted into an undersized pilot hole. The open proximal portion of the interference screw 100 advantageously promotes bone-to-tissue in-growth.


A convenient example of the interference screw 100 has a uniform taper 135. The threaded body 105 tapers from the proximal end 106 to the distal end 107. The taper 135 is advantageous to creating an interference fit between tissue and bone tunnel. When the interference screw 100 is inserted into the bone tunnel, the surface of the taper 135 fully contacts the tissue and drives it laterally into engagement with the opposing side wall of the bone tunnel. Greater contact between the interference screw 100 and tissue increases the pullout strength of the interference screw 100 and/or tissue.


The interference screw 100 further includes a cannulation 140 within the threaded body 105. The cannulation 140 extends longitudinally between the proximal end 106 and distal end 107 of the threaded body 105. In other words, the interference screw 100 may include an open helical coil defining an internal volume. The internal volume communicates with a region exterior to the open helical coil through the at least one opening 115 between the threads of the threaded body 105. There is a supporting spline 145 (three shown) extending longitudinally along the cannulation 140. The cannulation 140 and supporting spline 145 cooperatively engage a driver. The use of two or more supporting spline 145, rather than one supporting spline 145, may be advantageous because it may distribute the load imposed during rotation over a larger surface area.



FIGS. 2A and 2B show another example of the interference screw 100. The interference screw 100 has threads 110 with a thread base width (W). In a convenient example, the thread base width is approximately 2.54 mm. One of the advantages of the interference screw 100 over other screws with thinner thread base widths is greater torsional strength and/or flexural strength.



FIGS. 3A and 3B shows an example driver 150 used to insert the interference screw 100 into a bone tunnel (hole). The driver 150 includes a handle assembly (not shown) and a shaft 155 coupled to the handle assembly. The shaft 155 includes a distal end 156. The distal end 156 includes grooves (drive members) 160 and a distal stop 165. The grooves 160 extend a partial length of the shaft 155. The distal stop 165 is for use with a depth stop on the interference screw 100, which the driver 150 is used to implant into a bone tunnel during a tissue repair procedure, such as ligament reconstruction surgery.


The distal end 156 of the shaft 155 is placed within the cannulation 140 of the interference screw 100 until the depth stop engages the distal stop 165 of the shaft 155. At this stopping point, the entire length of the interference screw 100 is fully supported by the driver 150. When the interference screw 100 is fully supported, the interference screw 100 is engaged by the driver 150, distributing the load across the entire length of the interference screw 100. FIG. 3C shows an example in which an interference screw is not fully supported, resulting in no torque applied to the tip of the interference screw, increasing the risk of screw breakage during insertion.


During insertion of the shaft 155 into the interference screw 100, the supporting splines 145 engage the grooves 160 and become housed within the grooves 160. A convenient example of the driver 150 includes a groove 160 for receiving substantially an entire length of the supporting spline 145. The interference screw 100 being mounted on the driver 150 such that the supporting spline 145 is substantially captured by the groove 160 of the driver 150. Rotating the driver 150 causes the interference screw 100 to rotate.


In example shown in FIGS. 3A and 3B, surface of the cannulation 140 and surface of the distal end 156 of driver 150 are tapered, expanding outwardly in the proximal direction, so that interference screw 100 and driver 150 form a positive seat. The surface of the cannulation 140 of the interference screw 100 is in direct contact with the tapered body diameter of the driver 150.


A convenient example of the driver 100 includes a tapered seat-forming thread (e.g., a tapered cutting thread, a tapered opening or dilating thread, etc.) formed in shaft distal to the grooves. Tapered seat-forming thread serves to precede interference screw into the space between the tissue and the wall of the bone tunnel, and then to form a lead-in or opening in the tissue and the wall of the bone tunnel for receiving the threads of threaded body, in much the same manner as a tap that creates a thread form.


During tissue (e.g., ligament) reconstruction surgery, for example, the end of the tissue (e.g., graft ligament) is placed in the bone tunnel and then the interference screw 100 is advanced into the bone tunnel via the use of driver 150 so that the interference screw 100 extends parallel to the bone tunnel and simultaneously engages both the tissue and the side wall of the bone tunnel. The interference screw 100 may be used in either the femoral or tibial tunnels, for example.



FIGS. 4A-D show an example of another interference screw 200. The interference screw 200 includes a threaded body 205 having a proximal end 206 and a distal end 207. The interference screw 200 further includes a tip 210 disposed at the distal end 207 of the threaded body 205. The tip 210 has a proximal end 211 and a distal end 212, and a taper 215. The tip 210 tapers from the proximal end 211 to the distal end 212. The tip 210 is advantageous to inserting the interference screw 200 into an undersized bone tunnel filled with a tissue graft. The distal end 212 of the tip 210 has a diameter smaller than the opening to the bone tunnel and, thus, allows compressive forces to be gradually placed upon both the bone tunnel and the tissue graft.


In one example of the interference screw 200, the threaded body 205 has a constant diameter. In another example of the interference screw 200, the threaded body 205 includes a taper different than the taper 215 of the tip 210. The threaded body 205 tapering from the proximal end to distal end (e.g., a 2 degree taper). The taper of the threaded body 205 is advantageous to creating an interference fit between tissue and bone tunnel. When the interference screw 200 is inserted into the bone tunnel, the surface of the taper fully contacts the tissue and drives it laterally into engagement with the opposing side wall of the bone tunnel. Greater contact between the interference screw 200 and tissue increases the pullout strength of the interference screw 200 and/or tissue. Because of the taper 215 of the tip 210, this example of the interference screw 200 is also easier to insert into a bone tunnel.


A majority of the threaded body 205 includes screw threads 220 in the form of a helical coil, i.e. a connected series of continuous regularly spaced turns extending in a helical or spiral form substantially from the proximal end 206 to the distal end 207. The interference screw 200 further includes at least one opening 225 being defined by a surface between the threads 220 of the threaded body 205. The opening 225 is further defined by a ratio of open surface area to closed surface area. This ratio is advantageous to promoting desirable bone-to-tissue in-growth through the opening 225. This ratio is also advantageous to providing structural strength (e.g., torsional and/or flexural), such that the interference screw 200 resists breaking when inserted into an undersized bone tunnel to create an interface fit between a bone tunnel and tissue. It may convenient to refer to the ratio as a measure of degree of openness of an open architecture interference screw.


A convenient example of the interference screw 200 has a ratio of open surface area to closed surface area that is a function of the diameter and length of the interference screw 200. For example, the ratio of open surface area to closed surface area increases as the length and/or diameter of the interference screw 200 increases. Described below in greater detail, a large-sized example of the interference screw 200, having a diameter of 11 mm-12 mm and a length of 30 mm-35 mm, has a ratio of about one unit of open surface area to about three units of closed surface area. A medium-sized example of the interference screw 200, having a diameter of 7 mm-10 mm and length of 20-35 mm, has a ratio of about one unit of open surface area to about four units of closed surface area. A small-sized example of the interference screw 200, having a diameter of 5-6 mm and a length of 20 mm-25 mm, has a ratio of about one unit of open surface area to about five units of closed surface area.


As best seen in FIG. 4A, there are openings 225 between adjacent proximal threads 230a,b of the interference screw 200. The interference screw 200 also includes closed surfaces 235 between adjacent distal threads 240a,b. As shown, the interference screw 200 is arranged with an open proximal portion and closed distal portion. This arrangement is advantageous because the closed surface enhances the torsional strength, compressive strength, and/or flexural strength of the distal portion 207 of the interference screw 200. Increased structural strength is desirable at the distal end of the interference screw 200 because it is prone to breaking as the interference screw 200 is inserted into an undersized bone tunnel. The open proximal portion of the interference screw 200 advantageously promotes bone-to-tissue in-growth.


The interference screw further includes a cannulation 245 within the threaded body 205. The cannulation 245 extends longitudinally between the proximal end 206 and distal end 207 of the threaded body 205. In other words, the interference screw 200 may include an open helical coil defining an internal volume. The internal volume communicates with a region exterior to the open helical coil through the at least one opening 225 between the threads 220 of the threaded body 205. There is a supporting spline 250 (four shown) extending longitudinally along the cannulation 245. The cannulation 245 and supporting spline 250 cooperatively engage a driver.


A convenient example of the interference screw 200 includes, at the proximal end 206, a screw head 290. The screw head 290 has a surface 290a that extends smoothly and continuously from the threaded body 205 into a hemispherical-like end portion 290b, as shown. In use, the screw head 290 rests against graft material and damage to graft fibers is possible. Beneficially, this arrangement of the surface 290a and hemispherical-like end portion 290b reduces the chance of such damage.



FIGS. 5A-D show another example of the interference screw 200. The interference screw 200 includes a proximal portion of continuous openings 255. The continuous openings 255 are defined by a surface between proximal threads 230a,b. The continuous openings 255 completely encircle the interference screw 200. The proximal portion of continuous openings 255 advantageously promotes bone-to-tissue in-growth.


The interference screw 200 further includes a distal portion of discontinuous openings 260. The discontinuous openings are defined by a surface between distal threads 240a,b. Along a path of the surface, the surface alternates openings 225 and closed surface areas 235. This alternating pattern of openings 225 and closed surface areas 235 improves the torsional and flexural strength of the distal portion of the interference screw 200 that advantageous to insert in the interference screw 200 into a bone tunnel.


In the example of the interference screw 200 shown, the openings 225 and closed surface areas 235 of the distal portion of discontinuous openings are arranged 90° to each other. For example, there is opening 225 and when the interference screw 200 is rotated 90°, there is a closed surface area 235. It may be convenient to call this arrangement of the openings 225 and closed surface areas 235 asymmetrical. Other arrangements are possible, for example the openings 225 and closed surface areas 235 are arranged at an angle less than 90° or greater than 90°. The interference screw 200 with asymmetrical arrangement of openings 225 and closed surface areas 235 has a tip strength greater than an interference screw with openings only. High tip strength is advantageous to inserting the interference screw 200 into a undersized bone tunnel.


The example of the interference screw 200 may be described as having a threaded body 205 with a number of sides (e.g., four). The first side of the threaded body 205 includes a first series of rectangular-shaped (or the regular shape) openings 265 extending from the proximal end 206 to the distal end 207 of the interference screw 200. (Best seen in FIG. 5B.) The first series of openings 265 has a first length. A second side of the threaded body 205 includes a second series of rectangular-shaped openings 270 extending from the proximal end 206 to the distal end 207 of the interference screw 200. (Best seen in FIG. 5A.) The second series 270 has a second length shorter than the first length. (Best seen in FIG. 5D.) The foregoing arrangement repeats on the remaining sides (i.e., long series of openings, short series of openings, long series of openings, short series of openings, etc.).


The result of the foregoing arrangement is a region near the distal end 207 of the interference screw 200 in which the openings 225 are between closed surface areas 235. The strength of the surrounding closed surface areas 235 compensate for the weakness caused by the openings 225 in the interference screw 200. This arrangement improves tip strength that is advantageous to inserting the interference screw 200 into a bone tunnel.



FIGS. 6A-C show another example of the interference screw 200. The interference screw 200 has threads 220 with a thread base width (W). In a convenient example, the thread base width is approximately 1.0 mm. One of the advantages of the interference screw 200 over other screws with thinner thread base widths is greater torsional strength and/or flexural strength.



FIGS. 7A-C show another example of the interference screw 200. The interference screw 200 has an alternating pattern of openings 225 and closed surface areas 235. The alternating pattern extends over a length or substantially the entire length of the interference screw 200 (as shown). The openings 225 are between alternating pairs of adjacent threads 275. For example, the opening 225a is between a first pair of adjacent threads 275a and the opening 225b is between a second pair of adjacent threads 275b. The closed surface areas 235 are between alternating pairs of adjacent threads 275. For example, the closed surface areas 235a is between a third pair of adjacent threads 275c and the closed surface area 235b is between a fourth pair of adjacent threads 275d.



FIGS. 8A-C show another example of the interference screw 200. The interference screw 200 includes a proximal portion of uniform openings 280. The uniform opening 280 advantageously promote bone-to-tissue in-growth. The interference screw 200 further includes a distal portion of alternating pattern of openings and closed surface areas 285. (The alternating pattern is described above with reference to FIGS. 7A-C.) The alternating pattern of openings and closed advantageously increases tip strength.



FIGS. 9A and 9B shows an example driver 300 used to insert the interference screw 200 into a bone tunnel (hole). The driver 300 includes a handle assembly (not shown) and a shaft 305 coupled to the handle assembly. The shaft includes a distal end 306 and a driving member 310 (four shown) extending from the distal end 306, and an opening for a guide wire used to position the screw during insertion (not shown). If desired, the drive member 310 extends a partial length of the shaft 305. The driving member 310 includes driving surfaces 315a,b for engaging the corresponding surfaces of the supporting spline 245.


The distal end 306 of the shaft 305 is placed within the cannulation 245 of the interference screw 200. When inserting the interference screw 200 into the bone tunnel, the entire length of the interference screw 200 is fully supported by the driver 300. This distributes the load across the entire length of the interference screw 200, reducing the risk of breakage during insertion.


In example shown in FIGS. 9A and 9B, surface of the cannulation 245 and surface of the distal end 306 of driver are tapered, expanding outwardly in the proximal direction, so that interference screw 200 and driver 300 form a positive seat. The surface of the cannulation 245 of the interference screw 200 is in direct contact with the tapered body diameter of the driver 300.



FIGS. 10A-D show an example of another interference screw 400. The interference screw 400 is similar to the interference screw 200 of FIGS. 4A-D with exception of the tip. The interference screw 400 includes a threaded body 405 and tapered tip 410 extending from the threaded body 405. With reference to FIG. 10B, the tapered tip 410 has a proximal region 415, distal region 420, and surface 425 extended between the proximal and distal regions 415, 420.


An example of the tapered tip 410 has a first partial thread 430 and second partial thread 435 extending partway or less than 360° around the tapered tip 410. The first and second threads 430, 435 each start and stop at different locations on the surface 425 of the tapered tip 410. In a convenient example of the tapered tip 410, the first partial thread 430 starts in the distal region 420 at point 440a and extends about 180° around the tapered tip 410 (best seen in FIGS. 10C and 10D with the threaded body 405 is removed for clarity) and stops at point 440b in the proximal region 415. The second partial thread 435 starts at point 445a distal to the stopping point 440b of the first partial thread 430. The second partial thread 435 extends about 180° around the tapered tip 410 (also best seen in FIGS. 10C and 10D) and stops at point 445b in the proximal region 415. The stopping point 440b of the first partial thread 430 and starting point 445a of the second partial thread 435 are spaced a distance D from one another. In other examples of the tapered tip 410, the first partial thread 430 and the second partial thread 435 are discontinuous or separate from one another.


In one example of the tapered tip 410, the partial threads 430, 435 taper towards the proximal region 415 with the same taper as the tapered tip 410. The minimum diameter of a given partial thread is at the distal terminus of the partial thread. The diameter of the partial thread increases to a maximum towards the proximal region 415 of the tapered tip 410. In a convenient example, the partial threads 430, 435 each have tapered ends, of which tapered ends 430a and 435a are shown in FIG. 10B. Each of the tapered ends has a height above the surface 425 of the tapered tip 410 and terminates at the same height as the surface 425. The smooth transition between the partial threads 430, 435 and the surface 425 of the tapered tip 410 advantageously minimizes damage to a graft from the interference screw 400.


Tracing an example of the partial thread with tapered ends, starting from the distal terminus of the partial thread, the diameter of the partial thread increases until a maximum is reached near the proximal region 415. Continuing to trace the partial thread past the maximum diameter, the diameter of the partial thread decreases until the proximal terminus of the partial thread is reached. In foregoing example, the partial thread extends about 180° around the tapered tip 410 but reaches a maximum diameter (and maximum root diameter) in less than 180°.


A convenient example of the tapered tip 410 has partial threads with a constant height and width. Another example of the tapered tip 410 has partial threads that are larger in the distal region 420 and decrease in size towards the proximal region 415. This arrangement provides an aggressive initial bite or purchase of surrounding tissue. Another example of the tapered tip 410 has partial threads that are smaller in the distal region 420 and increase in size towards the proximal region 415. This arrangement provides an initial bite less aggressive than the prior example.


In a convenient example of the tapered tip 410, the partial threads have a thread pitch greater than that of the threaded body 405. For example, the thread pitch of the partial threads on the tapered tip 410 is one-and-a-half to two times that of the threaded body 405. The larger thread pitch of the partial thread allows the tapered tip 410 to rapidly engage the surrounding tissue or bone tunnel.


While the foregoing examples of the tapered tip 410 are described as having two partial threads, it should be apparent that any number of partial threads are possible, such as three or four. For example, FIG. 11 shows another example of the tapered tip 410 with one partial thread 450 extending partway or about 300° around the tapered tip 410.


In some examples of the interference screw 100, 200, 400 the threaded body 105, 205, 405 has a wall thickness of 0.5-3.25 mm. In other examples of the interference screw 100, 200, 400 the threaded body 105, 205, 405 has a wall thickness that is a function of the diameter and length of the screw.


In some examples of the interference screw 100, 200, 400 the supporting spline(s) 145, 250 has a width of 1-2.5 mm. Advantageously, a wide supporting spline distributes a torsional load better than a narrower supporting spline.


In some examples, the interference screw 100, 200, 400 may be completely or a portions thereof (e.g., the threaded body) made from a formulation of poly(lactic-co-glycolic) acid (PLGA), β-Tricalcium phosphate (β-TCP) and calcium sulfate, poly-L-lactic acid-hydroxyapatite (PLLA-HA), poly-D-lactide (PDLA), polyether ether ketone (PEEK) or variants thereof. Biocomposite examples of the interference screw 100, 200, 400 made from a combination of PLGA, β-TCP, and calcium sulfate are absorbable by the body, which is beneficial to natural healing. An example formulation of PLGA, β-TCP, and calcium sulfate is described in U.S. Pat. No. 8,545,866, the entirety of which is herein incorporated by reference. A copolymer of polyglycolic acid (PGA) and polytrimethylene carbonate (TMC) is another example of a bioabsorbable material. Other commonly used materials for implants are also contemplated by this disclosure. In any case, the interference screw 100, 200, 400 comprise a material that is capable of providing the strength needed to set the fixation device into position and to hold the tissue in position while bone-to-tissue in-growth occurs.


To examine the performance of the open-architecture interference screw, finite element analysis was used to simulate inserting the screw into an undersized bone tunnel with a delivery device. In the analysis, torque (torsional load) was applied to the inner portion of the screw that is in contact with the delivery device while the distal end of the screws was held in place. The torque at which the sample plastically deformed was recorded as the failure torque. The failure torque provides a measure of the torsional strength of a screw. The results of the analysis for a medium-size or 7 mm×25 mm (diameter by length) interference screw made from the formulation of PLGA, β-TCP, and calcium sulfate, described above, is provided below. (Similar results were found when the interference screw is made from PLLA-HA.)


















Failure Torque
Open Area to Closed



Sample
(in * lb)
Area Ratio



















1
Control (solid screw)
18.26
0 to 1


2
Sample 1
17.2
 1 to 11


3
Sample 2
15.23
 1 to 11


4
Sample 3
13.86
1 to 5


5
Sample 4
16
1 to 4


7
Sample 5
13.33
1 to 3


8
Sample 6
5.59
1 to 2









A control with no openings (i.e., solid screw) had the highest failure torque (18.26 in*lb). From this baseline, samples of increasing degrees of openness were analyzed. In some samples, the degree of openness was attached with openings. In other samples, supporting splines or thread defining the openings were adjusted as well. It was observed that increasing the degree of openness decreased the failure torque.


Unexpectedly, increasing the degree of openness to one unit of open surface area to three units of closed surface area did not further decrease the torsional strength of the screw total but improved the torsional strength (increased from 13.86 to 16 in*lb). Increasing the degree of openness beyond this ratio, however, did not improve the performance but rather decreased performance (decreased from 16 to 13.33 in*lb). The results, therefore, demonstrate that for a medium-sized screw (e.g., 8 mm×25 mm), a ratio of about one unit of open surface area to about four units of closed surface area provides superior results. The results also demonstrated that, surprisingly, thickening the supporting splines provided better performance then thickening the threads of the screw.


Similar testing was performed with other sizes of screws. For a large-sized screw (e.g., 12 mm×25 mm), a ratio of about one unit of open surface area to about three units of closed surface area was determined to provide superior results. For a small-sized screw (e.g., 6 mm×20 mm), a ratio of about one unit of open surface area to about five units of closed surface area was determined to provide superior results. In some examples, increasing the wall thickness of the screw (e.g., when increasing the size of the screw), also increased the degree of openness.


For a large-sized screw (e.g., 12 mm×25 mm) made from PEEK, a ratio of about one unit of open surface area to about two units of closed surface area was determined to provide superior results. For a medium-sized screw (e.g., 8 mm×25 mm) made from PEEK, a ratio of about one unit of open surface area to about two units of closed surface area and a half was determined to provide superior results. For a small-sized screw (e.g., 6 mm×20 mm) made from PEEK, a ratio of about one unit of open surface area to about three and a half units of closed surface area was determined to provide superior results.


As various modifications could be made to the examples, as described above with reference to the corresponding illustrations, without departing from the scope of the disclosure, it is intended that all matter contained in the foregoing description and shown in the accompanying drawings shall be interpreted as illustrative rather than limiting. Thus, the breadth and scope of the present disclosure should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims appended hereto and their equivalents. As used herein, the meaning of approximately, substantially, and about include their ordinary and customary meanings as well as being a certain percentage of a stated value e.g., 0.1%, 1%, and 10%.

Claims
  • 1. An open-architecture interference screw for creating an interference fit between a bone tunnel and tissue, the screw comprising: a threaded body having a proximal end and a distal end, and a thread extending around the threaded body between the proximal end and distal end;at least one supporting spline extending along a cannulation through the threaded body between the proximal end and distal end, the at least one supporting spline engagable with a delivery device;at least one opening defined by an open surface between the thread, the at least one opening having a ratio of open surface area to closed surface area, the ratio being selected such that, when torsionally loaded, the screw does not exhibit plastic deformation when inserted into an undersized bone tunnel; anda tapered tip extending from the distal end of the threaded body, the tapered tip having a thread extending at least partway around the tapered tip;wherein a surface of the cannulation is tapered toward the distal end of the threaded body so as to form a positive seat with a corresponding tapered surface of the delivery device when the delivery device is engaged with the at least one supporting spline.
  • 2. The open-architecture interference screw of claim 1 wherein the thread of the tapered tip extends at least one full turn around the tapered tip.
  • 3. The open-architecture interference screw of claim 2 wherein the thread of the tapered tip is a continuation of the thread of the threaded body.
  • 4. The open-architecture interference screw of claim 1 wherein the thread of the tapered tip is a partial thread extending less than one full turn around the tapered tip.
  • 5. The open-architecture interference screw of claim 4 wherein the partial thread includes a first partial thread and a second partial thread, each extending a half turn around the tapered tip.
  • 6. The open-architecture interference screw of claim 4 wherein the threaded body and tapered tip each have a different thread pitch.
  • 7. The open-architecture interference screw of claim 6 wherein the thread pitch of the tapered tip is between 1.5 and 3 times greater than the thread pitch of the threaded body.
  • 8. The open-architecture interference screw of claim 1 wherein the threaded body has a constant diameter.
  • 9. The open-architecture interference screw of claim 1 wherein the threaded body has a wall thickness of 0.5-3.25 mm.
  • 10. The open-architecture interference screw of claim 1 wherein the threaded body has a wall thickness that is a function of the diameter and length of the screw.
  • 11. The open-architecture interference screw of claim 1 wherein the at least one supporting spline has a width of 1-2.5 mm.
  • 12. The open-architecture interference screw of claim 1 wherein the thread has a base width of 0.76-2.54 mm.
  • 13. The open-architecture interference screw of claim 1 wherein the ratio of open surface area to closed surface area is a function of the diameter and length of the screw.
  • 14. The open-architecture interference screw of claim 1 wherein the screw has a diameter of 11-12 mm and a length of 30-35 mm; and wherein the ratio is about one unit of open surface area to about three units of closed surface area.
  • 15. The open-architecture interference screw of claim 1 wherein the screw has a diameter of 7-10 mm and a length of 20-35 mm; and wherein the ratio is about one unit of open surface area to about four units of closed surface area.
  • 16. The open-architecture interference screw of claim 1 wherein the screw has a diameter of 5-6 mm and a length of 20-25 mm; and wherein the ratio is about one unit of open surface area to about five units of closed surface area.
  • 17. The open-architecture interference screw of claim 1 wherein the at least one opening is defined by the open surface between adjacent proximal threads.
  • 18. The open-architecture interference screw of claim 1 wherein the at least one opening includes at least one continuous opening between adjacent proximal threads; and at least one discontinuous opening between adjacent distal threads, the at least one discontinuous opening having alternating segments of open surface area and closed surface area.
  • 19. The open-architecture interference screw of claim 1 wherein the at least one opening is defined by the open surface between alternating pairs of adjacent threads.
  • 20. The open-architecture interface screw of claim 1 wherein the threaded body further includes a screw head comprising a surface extending from the threaded body into a hemispherical-like end portion.
  • 21. The open-architecture interface screw of claim 1 wherein the screw is made from a combination of poly(lactic-co-glycolic) acid, β-Tricalcium phosphate, and calcium sulfate.
  • 22. A delivery device and open-architecture interference screw combination for creating an interference fit between a bone tunnel and tissue, the combination comprising: a delivery device comprising a handle and a shaft connected to the handle, the shaft including a distal portion having a driving member, a surface of the distal portion being tapered;an interference screw comprising: a threaded body having a proximal end and a distal end, and a thread extending around the threaded body between the proximal end and distal end;at least one supporting spline extending along a cannulation through the threaded body between the proximal end and distal end, the supporting spline engagable with a delivery device;at least one opening defined by an open surface between the thread, the at least one opening having a ratio of open surface area to closed surface area, the ratio being selected such that, when torsionally loaded, the screw does not exhibit plastic deformation when inserted into an undersized bone tunnel; anda tapered tip extending from the distal end of the threaded body, the tapered tip having a thread extending at least partway around the tapered tip;wherein the interference screw is located on the distal portion of the delivery device such that the driving member engages the at least one supporting spline of the interference screw; andwherein a surface of the cannulation is tapered toward the distal end of the threaded body so as to form a positive seat with the tapered surface of the distal portion of the delivery device when the delivery device is engaged with the at least one supporting spline.
CROSS-REFERENCE TO RELATED APPLICATION(S)

This application claims the benefit of U.S. Provisional Application No. 61/810,007, filed on Apr. 9, 2013, and entitled, “Open-architecture Interference Screw,” the entirety of which is hereby incorporated by reference.

US Referenced Citations (279)
Number Name Date Kind
2288864 Whitehead et al. Jul 1942 A
3316795 David May 1967 A
3320783 Kerr May 1967 A
3499222 Linkow et al. Mar 1970 A
3716058 Tanner Feb 1973 A
3821975 Haker Jul 1974 A
3869942 DeCaro Mar 1975 A
3874258 Semola et al. Apr 1975 A
4027572 Burge Jun 1977 A
4177797 Baylis et al. Dec 1979 A
D288777 Kwon Mar 1987 S
4653489 Tronzo Mar 1987 A
4738255 Goble et al. Apr 1988 A
4741651 Despres May 1988 A
4834757 Brantigan May 1989 A
4854311 Steffee Aug 1989 A
RE33114 Chiavon Nov 1989 E
4913143 Oloff et al. Apr 1990 A
4961740 Ray et al. Oct 1990 A
4988351 Paulos et al. Jan 1991 A
5026373 Ray et al. Jun 1991 A
5055104 Ray Oct 1991 A
5094133 Schreiber Mar 1992 A
5116337 Johnson May 1992 A
5129904 Illi Jul 1992 A
5129906 Ross et al. Jul 1992 A
5139520 Rosenberg Aug 1992 A
5197967 Wilson Mar 1993 A
5236431 Gogolewski et al. Aug 1993 A
5242447 Borzone Sep 1993 A
5312214 Morton May 1994 A
5354299 Coleman Oct 1994 A
5364400 Rego, Jr. et al. Nov 1994 A
5370662 Stone et al. Dec 1994 A
5383878 Roger et al. Jan 1995 A
5407427 Zhu et al. Apr 1995 A
5411506 Goble et al. May 1995 A
5411523 Goble May 1995 A
5423823 Schmieding Jun 1995 A
5431660 Burke Jul 1995 A
5447533 Vachon et al. Sep 1995 A
5464427 Curtis et al. Nov 1995 A
5470334 Ross et al. Nov 1995 A
5531780 Vachon Jul 1996 A
5571139 Jenkins, Jr. Nov 1996 A
5573548 Nazre et al. Nov 1996 A
5593409 Michelson Jan 1997 A
5609635 Michelson Mar 1997 A
5609636 Kohrs et al. Mar 1997 A
5626613 Schmieding May 1997 A
5632747 Scarborough May 1997 A
5645547 Coleman Jul 1997 A
5658285 Marnay et al. Aug 1997 A
5676545 Jones Oct 1997 A
5681352 Clancy, III et al. Oct 1997 A
5688285 Yamada Nov 1997 A
5690676 Dipoto et al. Nov 1997 A
5695497 Stahelin Dec 1997 A
5702397 Goble et al. Dec 1997 A
5709683 Bagby Jan 1998 A
5802794 Robson Sep 1998 A
5833715 Vachon et al. Nov 1998 A
5876405 Del Rio Mar 1999 A
5888227 Cottle Mar 1999 A
5891146 Simon et al. Apr 1999 A
5921982 Lesh et al. Jul 1999 A
5951560 Simon et al. Sep 1999 A
5961524 Crombie Oct 1999 A
5964783 Grafton et al. Oct 1999 A
5968047 Reed Oct 1999 A
5968098 Winslow Oct 1999 A
5984967 Zdeblick et al. Nov 1999 A
6008433 Stone Dec 1999 A
6039762 McKay Mar 2000 A
6086593 Bonutti Jul 2000 A
6096060 Fitts et al. Aug 2000 A
6097986 Janke et al. Aug 2000 A
6132435 Young Oct 2000 A
6146073 Kobusch Nov 2000 A
6196780 Wakai et al. Mar 2001 B1
6214031 Schmieding et al. Apr 2001 B1
6235057 Roger et al. May 2001 B1
6283973 Hubbard et al. Sep 2001 B1
6302632 Lin Oct 2001 B1
6360129 Ley et al. Mar 2002 B1
6443989 Jackson Sep 2002 B1
6447545 Bagby Sep 2002 B1
6488683 Lieberman Dec 2002 B2
6503251 Shadduck Jan 2003 B1
6511499 Schmieding et al. Jan 2003 B2
6514257 Dovesi et al. Feb 2003 B2
6517542 Papay et al. Feb 2003 B1
6527774 Lieberman Mar 2003 B2
6544265 Lieberman Apr 2003 B2
6551319 Lieberman Apr 2003 B2
6551320 Lieberman Apr 2003 B2
6551322 Lieberman Apr 2003 B1
6554830 Chappius Apr 2003 B1
6569188 Grafton et al. May 2003 B2
6589245 Weiler et al. Jul 2003 B1
6604945 Jones Aug 2003 B1
6626917 Craig Sep 2003 B1
6648903 Pierson Nov 2003 B1
6656183 Colleran et al. Dec 2003 B2
6666888 Jackson Dec 2003 B1
6685728 Sinnott et al. Feb 2004 B2
6818010 Eichhorn et al. Nov 2004 B2
6823871 Schmieding Nov 2004 B2
6855168 Crozet Feb 2005 B2
6857343 Easterbrooks Feb 2005 B1
6863671 Strobel Mar 2005 B1
6942669 Kurc Sep 2005 B2
6953462 Lieberman Oct 2005 B2
7033372 Cahalan Apr 2006 B1
7070586 Hart et al. Jul 2006 B2
7083647 Sklar et al. Aug 2006 B1
7090690 Foerster et al. Aug 2006 B2
7147641 Chen Dec 2006 B2
7189251 Kay Mar 2007 B2
7195634 Schmieding et al. Mar 2007 B2
7217279 Reese May 2007 B2
7322978 West Jan 2008 B2
7322986 Wolf Jan 2008 B2
7335221 Collier et al. Feb 2008 B2
7371244 Chatlynne et al. May 2008 B2
7572264 Null et al. Aug 2009 B2
7575572 Sweeney Aug 2009 B2
7585311 Green et al. Sep 2009 B2
7594929 Collette Sep 2009 B2
7608098 Stone et al. Oct 2009 B1
7867252 Criscuolo et al. Jan 2011 B2
7883529 Sinnott et al. Feb 2011 B2
7896902 Jeon et al. Mar 2011 B2
7914539 Stone et al. Mar 2011 B2
7935138 Richelsoph May 2011 B1
7993369 Dreyfuss Aug 2011 B2
8016865 Donnelly et al. Sep 2011 B2
8034090 Stone et al. Oct 2011 B2
8167906 Cauldwell et al. May 2012 B2
8343186 Dreyfuss et al. Jan 2013 B2
8372124 Paulk et al. Feb 2013 B2
8430909 Dreyfuss Apr 2013 B2
8449613 Crozet May 2013 B2
8480686 Bakos Jul 2013 B2
8597328 Cauldwell et al. Dec 2013 B2
8623049 Ward Jan 2014 B2
8623052 Dreyfuss et al. Jan 2014 B2
8636799 Sklar et al. Jan 2014 B2
8672967 Dimatteo et al. Mar 2014 B2
8715282 Pool May 2014 B2
8801755 Dreyfuss et al. Aug 2014 B2
8821541 Dreyfuss et al. Sep 2014 B2
8974505 Sawa et al. Mar 2015 B2
8979848 Butters et al. Mar 2015 B2
8979865 Fan et al. Mar 2015 B2
9155531 Housman Oct 2015 B2
9162350 Nino et al. Oct 2015 B2
9237887 Wack et al. Jan 2016 B2
9308080 Housman et al. Apr 2016 B2
9393006 Housman et al. Jul 2016 B2
9427270 Housman Aug 2016 B2
9526488 Arai et al. Dec 2016 B2
9579188 Bowman et al. Feb 2017 B2
20020022862 Grafton et al. Feb 2002 A1
20020052629 Morgan et al. May 2002 A1
20020055737 Lieberman May 2002 A1
20020055738 Lieberman May 2002 A1
20020055742 Lieberman May 2002 A1
20020087189 Bonutti Jul 2002 A1
20020087190 Benavitz et al. Jul 2002 A1
20020099382 Salazar et al. Jul 2002 A1
20020111653 Foerster Aug 2002 A1
20020143335 von Hoffmann et al. Oct 2002 A1
20020165546 Goble et al. Nov 2002 A1
20030055431 Brannon Mar 2003 A1
20030065361 Dreyfuss Apr 2003 A1
20030065374 Honeck Apr 2003 A1
20030069640 Ferreira et al. Apr 2003 A1
20030078585 Johnson et al. Apr 2003 A1
20030125749 Yuan et al. Jul 2003 A1
20030181913 Lieberman Sep 2003 A1
20030195529 Takamoto et al. Oct 2003 A1
20040015170 Tallarida et al. Jan 2004 A1
20040030343 Kurc Feb 2004 A1
20040039404 Dreyfuss Feb 2004 A1
20040073216 Lieberman Apr 2004 A1
20040093032 Sinnott et al. May 2004 A1
20040097945 Wolf May 2004 A1
20040122424 Ferree Jun 2004 A1
20040143158 Hart et al. Jul 2004 A1
20040143237 Hart et al. Jul 2004 A1
20040153074 Bojarski et al. Aug 2004 A1
20040267265 Kyle Dec 2004 A1
20050107828 Reese May 2005 A1
20050159727 Lesh Jul 2005 A1
20050222681 Richley et al. Oct 2005 A1
20050234458 Huebner Oct 2005 A1
20050250984 Lam et al. Nov 2005 A1
20050250985 Saadat et al. Nov 2005 A1
20050250987 Ewers et al. Nov 2005 A1
20050250988 Ewers et al. Nov 2005 A1
20050267478 Corradi et al. Dec 2005 A1
20050283239 Crozet Dec 2005 A1
20060009769 Lieberman Jan 2006 A1
20060030948 Manrique et al. Feb 2006 A1
20060079895 McLeer Apr 2006 A1
20060079903 Wong Apr 2006 A1
20060089651 Trudeau et al. Apr 2006 A1
20060100627 Stone et al. May 2006 A1
20060106390 Jensen et al. May 2006 A1
20060142769 Collette Jun 2006 A1
20060149266 Cordasco Jul 2006 A1
20060217681 Hart et al. Sep 2006 A1
20060241636 Novak et al. Oct 2006 A1
20060247642 Stone Nov 2006 A1
20060253080 Tulleken et al. Nov 2006 A1
20060276841 Barbieri et al. Dec 2006 A1
20070032797 Ortiz et al. Feb 2007 A1
20070093895 Donnelly et al. Apr 2007 A1
20070122764 Balfour et al. May 2007 A1
20070142849 Ewers et al. Jun 2007 A1
20070185532 Stone et al. Aug 2007 A1
20070198019 Schomer et al. Aug 2007 A1
20070203498 Gerber et al. Aug 2007 A1
20080027446 Stone et al. Jan 2008 A1
20080065114 Stone et al. Mar 2008 A1
20080082128 Stone Apr 2008 A1
20080132932 Hoeppner Jun 2008 A1
20080140092 Stone et al. Jun 2008 A1
20080140093 Stone et al. Jun 2008 A1
20080154314 McDevitt Jun 2008 A1
20080179839 Walters Jul 2008 A1
20080275431 Stone et al. Nov 2008 A1
20090024174 Stark Jan 2009 A1
20090042951 Danziger Feb 2009 A1
20090076544 DiMatteo et al. Mar 2009 A1
20090118776 Kelsch et al. May 2009 A1
20090125071 Skinlo et al. May 2009 A1
20090187216 Schmieding et al. Jul 2009 A1
20090248029 Paulos Oct 2009 A1
20090292321 Collette Nov 2009 A1
20090319043 McDevitt et al. Dec 2009 A1
20100094297 Parmigiani Apr 2010 A1
20100094352 Iott et al. Apr 2010 A1
20100106166 Cropper et al. Apr 2010 A1
20100274298 Schiff Oct 2010 A1
20110054526 Stone et al. Mar 2011 A1
20110112576 Nguyen et al. May 2011 A1
20110130760 Anderson et al. Jun 2011 A1
20110213426 Yedlicka et al. Sep 2011 A1
20110224727 Housman et al. Sep 2011 A1
20110282450 Donnelly et al. Nov 2011 A1
20110319933 Tepic Dec 2011 A1
20120041448 Schumacher et al. Feb 2012 A1
20120059384 Fan Mar 2012 A1
20120179163 Housman et al. Jul 2012 A1
20120330420 Brodke et al. Dec 2012 A1
20130150859 Kehres et al. Jun 2013 A1
20130158596 Miller et al. Jun 2013 A1
20130158597 Hernandez Jun 2013 A1
20130158598 Lizardi Jun 2013 A1
20130158599 Hester et al. Jun 2013 A1
20130158610 Hernandez Jun 2013 A1
20130178901 Arai et al. Jul 2013 A1
20140081339 Bowman et al. Mar 2014 A1
20140142697 Sklar et al. May 2014 A1
20140148850 Dimatteo et al. May 2014 A1
20140172016 Housman Jun 2014 A1
20140277129 Arai et al. Sep 2014 A1
20140277130 Housman Sep 2014 A1
20140277188 Poulos Sep 2014 A1
20140277192 Housman Sep 2014 A1
20150196388 Housman et al. Jul 2015 A1
20150327984 Arai et al. Nov 2015 A1
20160235399 Housman et al. Aug 2016 A1
20160374661 Housman et al. Dec 2016 A1
20170014224 Arai et al. Jan 2017 A1
20170020589 Bowman et al. Jan 2017 A1
20170049438 Arai et al. Feb 2017 A1
Foreign Referenced Citations (72)
Number Date Country
2732211 Oct 2005 CN
1701772 Nov 2005 CN
1829479 Sep 2006 CN
101002703 Jul 2007 CN
101031248 Sep 2007 CN
101422381 May 2009 CN
101422381 May 2009 CN
101573078 Nov 2009 CN
201436022 Apr 2010 CN
102068305 May 2011 CN
102475586 May 2012 CN
102512253 Jun 2012 CN
102525583 Jul 2012 CN
102551821 Jul 2012 CN
102781370 Nov 2012 CN
102905636 Jan 2013 CN
102573662 Aug 2015 CN
3502698 Sep 1992 EP
05202698 Sep 1992 EP
0538895 Apr 1993 EP
0682917 Nov 1995 EP
0686373 Dec 1995 EP
0669110 May 2000 EP
1147751 Oct 2001 EP
1093774 Jun 2002 EP
1234637 Aug 2002 EP
0796593 May 2004 EP
1430843 Jun 2004 EP
1917926 Jul 2008 EP
2036501 Sep 2010 EP
2422711 Feb 2012 EP
2422712 Feb 2012 EP
2596758 May 2013 EP
2601894 Jun 2013 EP
2760355 Sep 1998 FR
2803739 Jul 2001 FR
2846867 May 2004 FR
2879915 Jun 2006 FR
2879915 Jun 2006 FR
2294399 May 1996 GB
H10-000200 Jan 1998 JP
H10200 Jan 1998 JP
2005-529650 Oct 2005 JP
2006-212449 Aug 2006 JP
2006-305348 Nov 2006 JP
9608205 Mar 1996 WO
1996-19947 Jul 1996 WO
9619947 Jul 1996 WO
1998-02117 Jan 1998 WO
9802117 Jan 1998 WO
9826717 Jun 1998 WO
2003-063713 Aug 2003 WO
03063713 Aug 2003 WO
03103507 Dec 2003 WO
03103507 Dec 2003 WO
2006055516 May 2006 WO
2007093192 Aug 2007 WO
2008-021474 Feb 2008 WO
2008021474 Feb 2008 WO
2008100944 Aug 2008 WO
2009-042951 Apr 2009 WO
2009042951 Apr 2009 WO
2010009217 Jan 2010 WO
2010017631 Feb 2010 WO
20100017584 Feb 2010 WO
2010053708 May 2010 WO
2011059995 May 2011 WO
2011060022 May 2011 WO
2011112776 Sep 2011 WO
20110112576 Sep 2011 WO
20120129388 Sep 2012 WO
2012171011 Dec 2012 WO
Non-Patent Literature Citations (58)
Entry
First Office Action for Chinese Patent Application No. 201180013194.3, dated Jul. 21, 2014.
International Search and Written Opinion for PCT/US2014/022539 dated Jun. 27, 2014.
International Search and Written Opinion for PCT/US2014/020747 dated Jun. 6, 2014.
Decision of Rejections for Japanese Patent Application No. 2011-538642, dated Jun. 2, 2014.
International Search and Written Opinion for PCT/US2014/066389 dated Feb. 17, 2015.
Notice of Reasons for Rejection for Japanese Patent Application No. 2012-557236 dated Mar. 2, 2015.
Patent Examination Report No. 1 for Australian Patent Application No. 2011224326 dated Apr. 21, 2015.
Second Office Action for Chinese Patent Application No. 201180013194.3, dated Mar. 23, 2015.
First Office Action for Chinese Patent Application No. 201280022627.6, dated Apr. 13, 2015.
Second Office Action for related Chinese Patent Application No. 201280022627.6 dated Sep. 16, 2015.
Substantive Examination for related Mexican Patent Application No. Mx/a/2013/010383 issued Aug. 12, 2015.
Patent Examination Report No. 1 for related Australian Patent Application No. 2012229152 Issued Aug. 18, 2015.
Third Office Action for related Chinese Patent Application No. 2011-80013194.3 issued Aug. 21, 2015.
International Preliminary Report on Patentability for related International Application No. PCT/US2014/033535, dated Oct. 22, 2015.
Decision of Rejection on related Japanese Patent Application No. 2012-557236 dated Oct. 9, 2015.
Communication from related European Patent Application No. 09761114.9 dated Dec. 3, 2015.
Communication from related European Patent Application No. 11710940.5 dated Dec. 8, 2015.
First Office Action for related Chinese Patent Application No. 201280038677.3 dated Sep. 6, 2015.
Patent Examination Report No. 1 for related Australian Patent Application No. 2012267924 dated Dec. 22, 2015.
Substantive Examination Report from related Mexico Patent Application No. MX/a/2013/010383 dated Jan. 19, 2016.
Notice of Reasons for Rejection for related Japanese Application No. 2013-558094 dated Feb. 2, 2016.
Substantive Examination of related Russian Application No. 2013144961/14(069526) dated Dec. 23, 2015.
Third Office Action from related Chines Application No. 201280022627.6 dated Mar. 4, 2016.
Second Office Action from related Chinese Application No. 201280038677.3 dated May 5, 2016.
International Preliminary Report on Patentability from related PCT Application No. PCT/US2014/066389 dated May 24, 2016.
Office Action from related Mexican Application No. MX/a/2013/010383 dated May 3, 2016.
Notice of Reasons for Rejection from related Japanese Application No. 2014-514625 dated Jun. 13, 2016.
Communication from EPO from related European Application No. 12711719.0-1666 dated Jul. 28, 2016.
Office Action from related Russian Application No. 2015147534/20(073143) dated Jun. 29, 2016.
Hunt, Patrick, D.V.M. et al. “Development of a Perforated Biodegradable Interference Screw” , Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 21, No. 3, Mar. 2005; pp. 258-265.
International Search and Written Opinion for PCT/US2011/027837 dated May 19, 2011.
Smith & Nephew brochure titled “Bio RCITM Bioabsorbable Screws: Anatomically Targeted Screws for ACL and PCL Reconstruction”, 2000.
Biomet brochure “Bio-CoreTM Interference Screw”, 2007.
International Search and Written Opinion for PCT/US2009/065304 dated Jun. 5, 2013.
International Search and Written Opinion for PCT/US2012/041298 dated Jun. 5, 2013.
International Search and Written Opinion for PCT/US2012/028803 dated Oct. 24, 2010.
Notice of Reasons for Rejections for Japanese Patent Application No. 2011-538642, dated Oct. 1, 2013.
First Office Action for Chinese Patent Application No. 200980155954.7, dated Apr. 12, 2013.
Second Office Action for Chinese Patent Application No. 200980155954.7, dated Oct. 24, 2013.
Notice of Reasons for Rejection for Japanese Patent Application No. 2012-557236 dated Nov. 25, 2014.
Patent Examination Report No. 1 for Australian Patent Application No. 2009319879 dated Nov. 10, 2014.
Office Action and Search Report from related Chinese Application No. 201480032876.2 dated Oct. 19, 2016.
Office Communication from related European Application No. 14712930.8-1662 dated Nov. 24, 2016.
Decision of Rejection from related Japanese Application No. 2013-558094 dated Sep. 5, 2016.
First Office Action from related Chinese Application No. 201480012203.0 dated Aug. 17, 2016.
Third Office Action from related Chinese Application No. 201280038677.3 dated Nov. 28, 2016.
Office Action from related Japanese Application No. 2014-514625 dated Dec. 19, 2016.
Office Action from related Russian Application No. 2016124173/20(037886) dated Jan. 19, 2017.
Office Action from related EPO Application No. 14716107.9-1664 dated Mar. 23, 2017.
Communication from related European Application No. 14724272.1-1664 issued Jun. 13, 2017.
First Office Action for Chinese Patent Application No. 201480073698.8 issued May 2, 2017.
First Office Action from related Chinese Application No. 201480014353.5 issued Apr. 19, 2017.
Fourth Office Action from related Chinese Application No. 201280038677.3 issued May 26, 2017.
International Search and Written Opinion for PCT/US2014/033535 dated Jul. 18, 2014.
Office Action from related Russian Application No. 2015147534/20(073143) issued Jun. 29, 2016.
Second Office Action for Chinese Patent Application No.: 201180013194.3, issued Mar. 23, 2015.
Second Office Action from related Chinese Application No. 201480012203.0 issued Apr. 24, 2017.
Second Office Action from related Chinese Application No. 201480032876.2 issued May 31, 2017.
Related Publications (1)
Number Date Country
20140303676 A1 Oct 2014 US
Provisional Applications (1)
Number Date Country
61810007 Apr 2013 US